Pages

Sunday, February 24, 2013

BREAKING NEWS: Massachusetts Specialty Pharmacy Announces Voluntary Recall


WALTHAM, Mass.--()--Village Fertility Pharmacy is conducting a voluntary recall of compounded medications shipped over the past three months. The recall resulted after particulate was discovered in a small percentage of two lots of Progesterone. Immediately upon learning of the situation, Village contacted the Massachusetts Board of Pharmacy.
“We are working cooperatively with all government agencies and are awaiting the results of the investigation”
After an initial investigation, Village and the Massachusetts Board of Pharmacy decided to expand the recall to include one other medication, Leuprolide. More testing is being conducted and results will be released in the coming days.
“We are working cooperatively with all government agencies and are awaiting the results of the investigation,” according to Stuart Levine, president of Village Fertility Pharmacy. “While no patients have reported any adverse effects, we believe the prudent course is to recall all of these medications.”
The recall includes:
  • Progesterone Injection Cottonseed Oil 50 MG/ML
  • Progesterone Injection Olive Oil 50 MG/ML, 100 MG/ML
  • Progesterone Injection Sesame Oil 50 MG/ML, 100 MG/ML
  • Progesterone Injection Ethyl Oleate 50 MG/ML, 100 MG/ML
  • Hydroxy Progesterone Caproate 250 MG/ML
  • Compounded Leuprolide Acetate 1MG/.2ML
Progesterone is a hormone that supports gestation. It is compounded in different solutions to accommodate patients’ various needs. Leuprolide suppresses natural ovulation.
Village Fertility Pharmacy is a pharmacist-owned and operated specialty fertility pharmacy dedicated to providing exceptional service and educational resources to fertility patients and clinics. Compounding represents five percent of the company’s total work.
Patients with questions can call the Village Recall Hotline at 1-888-965-5813.

Contacts

For Village Fertility Pharmacy
Matt Ellis, 617-278-6560
matt@ballcg.com

No comments:

Post a Comment